Robyn Goforth, PhD

Robyn Goforth, PhD
As Vice President Technology Assessment at VIC, Dr. Goforth leads technical and commercial evaluation of technologies ranging from medical devices to pharmaceuticals as well as scientific research tools and instrumentation. Dr. Goforth also serves as Chief Scientific Officer of VIC portfolio company, BiologicsMD ™

Recent Posts

Behind the Curtain: Opportunity Assessment at VIC

Ask ten people how best to assess the value of a new technology, and you’ll likely get ten different answers. Google "opportunity assessment", and you will find hundreds of different templates, worksheets, and...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Nob Hill Therapeutics Secures Series A Funding to Advance Breakthrough Respiratory Technologies
Interview
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Zebra Analytix